IOL CHEMICALS & PHARM. | BAFNA PHARMA | IOL CHEMICALS & PHARM./ BAFNA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 17.8 | 73.9% | View Chart |
P/BV | x | 1.5 | 2.7 | 54.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. BAFNA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BAFNA PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ BAFNA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 141 | 380.6% | |
Low | Rs | 272 | 79 | 346.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 48.8 | 774.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 4.8 | 494.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.0 | 447.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 31.0 | 827.2% | |
Shares outstanding (eoy) | m | 58.71 | 23.66 | 248.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.3 | 47.6% | |
Avg P/E ratio | x | 17.1 | 22.9 | 74.5% | |
P/CF ratio (eoy) | x | 12.8 | 15.6 | 82.3% | |
Price / Book Value ratio | x | 1.6 | 3.5 | 44.6% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,596 | 914.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 159 | 1,060.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,154 | 1,922.1% | |
Other income | Rs m | 256 | 33 | 782.5% | |
Total revenues | Rs m | 22,427 | 1,186 | 1,890.6% | |
Gross profit | Rs m | 2,257 | 157 | 1,435.9% | |
Depreciation | Rs m | 462 | 53 | 865.4% | |
Interest | Rs m | 165 | 20 | 808.1% | |
Profit before tax | Rs m | 1,887 | 116 | 1,624.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 3 | 17,809.4% | |
Profit after tax | Rs m | 1,391 | 113 | 1,227.2% | |
Gross profit margin | % | 10.2 | 13.6 | 74.7% | |
Effective tax rate | % | 26.2 | 2.4 | 1,095.4% | |
Net profit margin | % | 6.3 | 9.8 | 63.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 873 | 1,107.1% | |
Current liabilities | Rs m | 5,025 | 465 | 1,081.2% | |
Net working cap to sales | % | 20.9 | 35.4 | 59.1% | |
Current ratio | x | 1.9 | 1.9 | 102.4% | |
Inventory Days | Days | 43 | 2 | 2,524.1% | |
Debtors Days | Days | 8 | 1,302 | 0.6% | |
Net fixed assets | Rs m | 11,017 | 423 | 2,606.3% | |
Share capital | Rs m | 587 | 237 | 248.2% | |
"Free" reserves | Rs m | 14,490 | 498 | 2,909.8% | |
Net worth | Rs m | 15,077 | 735 | 2,052.6% | |
Long term debt | Rs m | 0 | 84 | 0.0% | |
Total assets | Rs m | 20,684 | 1,296 | 1,596.2% | |
Interest coverage | x | 12.5 | 6.7 | 185.9% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 120.4% | |
Return on assets | % | 7.5 | 10.3 | 72.9% | |
Return on equity | % | 9.2 | 15.4 | 59.8% | |
Return on capital | % | 13.6 | 16.7 | 81.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 7.9 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 91 | 0.0% | |
Fx inflow | Rs m | 5,930 | 885 | 670.0% | |
Fx outflow | Rs m | 6,052 | 91 | 6,679.0% | |
Net fx | Rs m | -122 | 794 | -15.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 50 | 2,468.6% | |
From Investments | Rs m | -1,200 | -75 | 1,601.5% | |
From Financial Activity | Rs m | -41 | 102 | -40.4% | |
Net Cashflow | Rs m | -18 | 76 | -24.1% |
Indian Promoters | % | 48.2 | 88.4 | 54.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 11.6 | 447.8% | |
Shareholders | 130,003 | 7,367 | 1,764.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BAFNA PHARM. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -2.92% | -0.44% |
1-Month | -4.51% | 4.59% | 2.15% |
1-Year | -4.09% | -3.68% | 49.82% |
3-Year CAGR | -12.01% | -13.54% | 14.21% |
5-Year CAGR | 15.35% | 55.91% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BAFNA PHARM. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BAFNA PHARM. the stake stands at 88.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BAFNA PHARM..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BAFNA PHARM..
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.